Literature DB >> 29188510

Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.

Sandy S Hung1, Fan Li1,2, Jiang-Hui Wang1,3, Anna E King4, Bang V Bui5, Guei-Sheung Liu6,7,8, Alex W Hewitt9,10,11.   

Abstract

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein (Cas) is used by some bacteria and most archaea to protect against viral phage intrusion and has recently been adapted to allow for efficient editing of the mammalian genome. Whilst CRISPR/Cas-based technology has been used to modify genes in mammalian cells in vitro, delivery of CRISPR/Cas system into mammalian tissue and/or organs is more difficult and often requires additional vectors. With the use of adeno-associated virus (AAV) gene delivery system, active CRISPR/Cas enzyme can be maintained for an extended period of time and enable efficient editing of genome in the retina in vivo. Herein we outline the method to edit the genome in mouse retina using a dual AAV vector -mediated CRISPR/Cas9 system.

Entities:  

Keywords:  AAV; CRISPR/Cas9; Gene delivery; Genome editing; Retina

Mesh:

Year:  2018        PMID: 29188510     DOI: 10.1007/978-1-4939-7522-8_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

1.  Allele-Specific CRISPR-Cas9 Genome Editing of the Single-Base P23H Mutation for Rhodopsin-Associated Dominant Retinitis Pigmentosa.

Authors:  Pingjuan Li; Benjamin P Kleinstiver; Mihoko Y Leon; Michelle S Prew; Daniel Navarro-Gomez; Scott H Greenwald; Eric A Pierce; J Keith Joung; Qin Liu
Journal:  CRISPR J       Date:  2018-02

2.  Long-Term Effects of In Vivo Genome Editing in the Mouse Retina Using Campylobacter jejuni Cas9 Expressed via Adeno-Associated Virus.

Authors:  Dong Hyun Jo; Taeyoung Koo; Chang Sik Cho; Jin Hyoung Kim; Jin-Soo Kim; Jeong Hun Kim
Journal:  Mol Ther       Date:  2018-10-17       Impact factor: 11.454

3.  Dual-sgRNA CRISPR/Cas9 knockout of PD-L1 in human U87 glioblastoma tumor cells inhibits proliferation, invasion, and tumor-associated macrophage polarization.

Authors:  Javier Fierro; Jake DiPasquale; Joshua Perez; Brandon Chin; Yathip Chokpapone; An M Tran; Arabella Holden; Chris Factoriza; Nikhi Sivagnanakumar; Rocio Aguilar; Sarah Mazal; Melissa Lopez; Huanyu Dou
Journal:  Sci Rep       Date:  2022-02-14       Impact factor: 4.379

Review 4.  Gene-Based Therapeutics for Inherited Retinal Diseases.

Authors:  Beau J Fenner; Tien-En Tan; Amutha Veluchamy Barathi; Sai Bo Bo Tun; Sia Wey Yeo; Andrew S H Tsai; Shu Yen Lee; Chui Ming Gemmy Cheung; Choi Mun Chan; Jodhbir S Mehta; Kelvin Y C Teo
Journal:  Front Genet       Date:  2022-01-07       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.